Kathryn Berrier Sheets
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kathryn Berrier Sheets has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Campbell K. Brasington
3 shared publications- Zoheb B. Kazi
Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA
3 shared publications Alison Schwartz
Down Syndrome Program, Division of Genetics, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts
2 shared publicationsAngela Lombardo
Down Syndrome Program, Division of Developmental Medicine, Department of Medicine, Boston Children's Hospital, Boston, Massachusetts
2 shared publicationsBlythe Crissman
Comprehensive Down Syndrome Program, Division of Medical Genetics, Duke University Medical Center, Durham, North Carolina
2 shared publications- Brian G. Skotko
Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA
2 shared publications
Latest Publications
- 23 March 2017
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 173 (6) , 1539-1545
Thyroid dysfunction in patients with Down syndrome: Results from a multi‐institutional registry study
The goals of this undertaking were to assess the outcomes of thyroid screening tests and adherence to thyroid screening guidelines across five Down syndrome (DS) specialty clinics in various states. Data related to thyroid screening were collected for 663 individuals across five clinics specializing in the comprehensive care of individuals with DS for a period of 1 year. Of the 663 participants, 47.7% of participants had a TSH and free T4 ordered at their DS specialty clinic visit. Approximately 19.0% (60/316) had a new thyroid disorder diagnosis made. We conclude that a sizable proportion of the patients with DS are not up‐to‐date on current guidelines when they present to a DS specialty clinic, while adherence to thyroid screening guidelines helps facilitate early diagnoses. Hypothyroidism is prevalent in the population, consistent with reported literature. DS specialty clinics can help patients stay current on screening guidelines.
- 23 March 2017
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 173 (6) , 1539-1545
Thyroid dysfunction in patients with Down syndrome: Results from a multi‐institutional registry study
The goals of this undertaking were to assess the outcomes of thyroid screening tests and adherence to thyroid screening guidelines across five Down syndrome (DS) specialty clinics in various states. Data related to thyroid screening were collected for 663 individuals across five clinics specializing in the comprehensive care of individuals with DS for a period of 1 year. Of the 663 participants, 47.7% of participants had a TSH and free T4 ordered at their DS specialty clinic visit. Approximately 19.0% (60/316) had a new thyroid disorder diagnosis made. We conclude that a sizable proportion of the patients with DS are not up‐to‐date on current guidelines when they present to a DS specialty clinic, while adherence to thyroid screening guidelines helps facilitate early diagnoses. Hypothyroidism is prevalent in the population, consistent with reported literature. DS specialty clinics can help patients stay current on screening guidelines.
- 6 August 2015
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 167 (11) , 2520-2526
National down syndrome patient database: Insights from the development of a multi‐center registry study
The Down Syndrome Study Group (DSSG) was founded in 2012 as a voluntary, collaborative effort with the goal of supporting evidenced‐based health care guidelines for individuals with Down syndrome (DS). Since then, 5 DS specialty clinics have collected prospective, longitudinal data on medical conditions that co‐occur with DS. Data were entered by clinical staff or trained designees into the National Down Syndrome Patient Database, which we created using REDCap software. In our pilot year, we enrolled 663 participants across the U.S., ages 36 days to 70 years, from multiple racial and ethnic backgrounds. Here we report: (i) the demographic distribution of participants enrolled, (ii) a detailed account of our database infrastructure, and (iii) lessons learned during our pilot year to assist future researchers with similar goals for other patient populations.
- 6 August 2015
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 167 (11) , 2520-2526
National down syndrome patient database: Insights from the development of a multi‐center registry study
The Down Syndrome Study Group (DSSG) was founded in 2012 as a voluntary, collaborative effort with the goal of supporting evidenced‐based health care guidelines for individuals with Down syndrome (DS). Since then, 5 DS specialty clinics have collected prospective, longitudinal data on medical conditions that co‐occur with DS. Data were entered by clinical staff or trained designees into the National Down Syndrome Patient Database, which we created using REDCap software. In our pilot year, we enrolled 663 participants across the U.S., ages 36 days to 70 years, from multiple racial and ethnic backgrounds. Here we report: (i) the demographic distribution of participants enrolled, (ii) a detailed account of our database infrastructure, and (iii) lessons learned during our pilot year to assist future researchers with similar goals for other patient populations.
- 5 March 2015
- Published by Elsevier in Genetics in Medicine
- Vol. 17 (11) , 912-918
CRIM-negative infantile Pompe disease: characterization of immune responses in patients treated with ERT monotherapy
- 5 March 2015
- Published by Elsevier in Genetics in Medicine
- Vol. 17 (11) , 912-918
CRIM-negative infantile Pompe disease: characterization of immune responses in patients treated with ERT monotherapy
- 1 February 2015
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 114 (2) , S96
Consideration of increased dosing of alglucosidase alfa to achieve improved clinical outcomes in infantile Pompe disease
- 1 February 2015
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 114 (2) , S96
Consideration of increased dosing of alglucosidase alfa to achieve improved clinical outcomes in infantile Pompe disease
- 1 February 2015
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 114 (2) , S64
Prophylactic immume modulation in infantile Pompe disease: Collective experience treating CRIM-positive and negative patients in the naive setting
- 1 February 2015
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 114 (2) , S64
Prophylactic immume modulation in infantile Pompe disease: Collective experience treating CRIM-positive and negative patients in the naive setting
- 1 February 2015
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 114 (2) , S22
Discordant clinical responses in CRIM-positive IPD siblings demonstrate need for prophylactic ITI in the naive setting
- 1 February 2015
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 114 (2) , S22
Discordant clinical responses in CRIM-positive IPD siblings demonstrate need for prophylactic ITI in the naive setting
- 1 September 2011
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 66 (9) , 547-549
Balanced Information About Down Syndrome: What Is Essential?
The first information given to parents of children with newly diagnosed Down syndrome has a major impact on adaptation to the diagnosis and subsequent decision making. It is generally recommended that the information provided by genetic counselors be balanced, with positive and negative information. However, few studies have defined what “balanced” means, and genetic counselors and parents may have a different perspective with regard to the information needed. Prior studies evaluating types of information provided about Down syndrome by genetic counselors have not considered the information that parents of children with newly diagnosed Down syndrome believe to be important. This report used an online survey to examine the perspectives of genetic counselors and parents to establish a general consensus on the essential information that should be provided during initial discussion of a newly diagnosed Down syndrome in both prenatal and postnatal settings. Genetic counselors and parents were identified and surveyed through online contact with members of the National Down Syndrome Congress, National Down Syndrome Society, and National Society of Genetic Counselors. Of the total of 993 parents and 389 genetic counselors who started the online survey, 687 parents (69.2%) and 254 genetic counselors (65.2%) completed all sections. Participants rated each of 100 features of Down syndrome as essential, important but not essential, or not too important for the initial discussion of a diagnosis. The responses of parents and genetic counselors identified a total of 34 essential informational items to include. Essential items included how the diagnosis was made, clinical features, associated medical complications, available therapies, prognosis for intellectual disability, a range of potential outcomes, and informational resources and referrals. In addition to these 34 essential items, survey responses showed parents value information demonstrating the abilities and potentials of people with Down syndrome and that illustrate what life is like for a child and adult with Down syndrome. These findings show that to facilitate adaptation by families of affected infants to a new diagnosis of Down syndrome, the initial pre- and postnatal discussion should balance clinical information with the information that parents believe to be important.
- 1 September 2011
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 66 (9) , 547-549
Balanced Information About Down Syndrome: What Is Essential?
The first information given to parents of children with newly diagnosed Down syndrome has a major impact on adaptation to the diagnosis and subsequent decision making. It is generally recommended that the information provided by genetic counselors be balanced, with positive and negative information. However, few studies have defined what “balanced” means, and genetic counselors and parents may have a different perspective with regard to the information needed. Prior studies evaluating types of information provided about Down syndrome by genetic counselors have not considered the information that parents of children with newly diagnosed Down syndrome believe to be important. This report used an online survey to examine the perspectives of genetic counselors and parents to establish a general consensus on the essential information that should be provided during initial discussion of a newly diagnosed Down syndrome in both prenatal and postnatal settings. Genetic counselors and parents were identified and surveyed through online contact with members of the National Down Syndrome Congress, National Down Syndrome Society, and National Society of Genetic Counselors. Of the total of 993 parents and 389 genetic counselors who started the online survey, 687 parents (69.2%) and 254 genetic counselors (65.2%) completed all sections. Participants rated each of 100 features of Down syndrome as essential, important but not essential, or not too important for the initial discussion of a diagnosis. The responses of parents and genetic counselors identified a total of 34 essential informational items to include. Essential items included how the diagnosis was made, clinical features, associated medical complications, available therapies, prognosis for intellectual disability, a range of potential outcomes, and informational resources and referrals. In addition to these 34 essential items, survey responses showed parents value information demonstrating the abilities and potentials of people with Down syndrome and that illustrate what life is like for a child and adult with Down syndrome. These findings show that to facilitate adaptation by families of affected infants to a new diagnosis of Down syndrome, the initial pre- and postnatal discussion should balance clinical information with the information that parents believe to be important.
- 27 May 2011
- Published by Wiley in Journal of Genetic Counseling
- Vol. 20 (5) , 432-441
Practice Guidelines for Communicating a Prenatal or Postnatal Diagnosis of Down Syndrome: Recommendations of the National Society of Genetic Counselors
Down syndrome is one of the most common conditions encountered in the genetics clinic. Due to improvements in healthcare, educational opportunities, and community inclusion over the past 30 years, the life expectancy and quality of life for individuals with Down syndrome have significantly improved. As prenatal screening and diagnostic techniques have become more enhanced and widely available, genetic counselors can expect to frequently provide information and support following a new diagnosis of Down syndrome. This guideline was written for genetic counselors and other healthcare providers regarding the communication of a diagnosis of Down syndrome to ensure that families are consistently given up‐to‐date and balanced information about the condition, delivered in a supportive and respectful manner.
- 27 May 2011
- Published by Wiley in Journal of Genetic Counseling
- Vol. 20 (5) , 432-441
Practice Guidelines for Communicating a Prenatal or Postnatal Diagnosis of Down Syndrome: Recommendations of the National Society of Genetic Counselors
Down syndrome is one of the most common conditions encountered in the genetics clinic. Due to improvements in healthcare, educational opportunities, and community inclusion over the past 30 years, the life expectancy and quality of life for individuals with Down syndrome have significantly improved. As prenatal screening and diagnostic techniques have become more enhanced and widely available, genetic counselors can expect to frequently provide information and support following a new diagnosis of Down syndrome. This guideline was written for genetic counselors and other healthcare providers regarding the communication of a diagnosis of Down syndrome to ensure that families are consistently given up‐to‐date and balanced information about the condition, delivered in a supportive and respectful manner.
- 5 May 2011
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 155 (6) , 1246-1257
Balanced information about Down syndrome: What is essential?
The purpose of this study was to explore the perspectives of genetic counselors and parents of children with Down syndrome to define essential information for the initial discussion of a new diagnosis. We compared information given in both prenatal and postnatal settings, and also aimed to distinguish differences between the informational needs of parents and the information genetic counselors provide. Online surveys were distributed to members of the National Down Syndrome Congress, National Down Syndrome Society, and National Society of Genetic Counselors. Participants included 993 parents of children with Down syndrome and 389 genetic counselors. Participants rated 100 informational features about Down syndrome as Essential, Important, or Not Too Important for inclusion in the first discussion of the diagnosis. Responses identified 34 essential informational items for the initial discussion of Down syndrome, including clinical features, developmental abilities, a range of prognostications, and informational resources. Healthcare providers should consider incorporating these items in their initial discussion of a diagnosis in both prenatal and postnatal settings. Statistically significant differences between parent and genetic counselor responses illustrate that information is valued differently and that parents appreciate information about the abilities and potential of people with Down syndrome, as opposed to clinical details. Balancing clinical information with other aspects of the condition, as well as a better understanding of the information parents consider most important, may enable healthcare professionals to more effectively satisfy families' informational needs following a new diagnosis of Down syndrome.
- 5 May 2011
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 155 (6) , 1246-1257
Balanced information about Down syndrome: What is essential?
The purpose of this study was to explore the perspectives of genetic counselors and parents of children with Down syndrome to define essential information for the initial discussion of a new diagnosis. We compared information given in both prenatal and postnatal settings, and also aimed to distinguish differences between the informational needs of parents and the information genetic counselors provide. Online surveys were distributed to members of the National Down Syndrome Congress, National Down Syndrome Society, and National Society of Genetic Counselors. Participants included 993 parents of children with Down syndrome and 389 genetic counselors. Participants rated 100 informational features about Down syndrome as Essential, Important, or Not Too Important for inclusion in the first discussion of the diagnosis. Responses identified 34 essential informational items for the initial discussion of Down syndrome, including clinical features, developmental abilities, a range of prognostications, and informational resources. Healthcare providers should consider incorporating these items in their initial discussion of a diagnosis in both prenatal and postnatal settings. Statistically significant differences between parent and genetic counselor responses illustrate that information is valued differently and that parents appreciate information about the abilities and potential of people with Down syndrome, as opposed to clinical details. Balancing clinical information with other aspects of the condition, as well as a better understanding of the information parents consider most important, may enable healthcare professionals to more effectively satisfy families' informational needs following a new diagnosis of Down syndrome.